𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer: Abstracted from: Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–42

✍ Scribed by Michael A. Choti

Book ID
116394922
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
246 KB
Volume
30
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy with oxaliplatin,
Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51
📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB